bluebird bio Inc Receives FDA Accelerated Approval for SKYSONA Call Transcript
Good day, and welcome to the SKYSONA launch call. (Operator Instructions) As a reminder, this call may be recorded.
I would now like to turn the call over to Courtney O'Leary, Investor Relations. You may begin.
' -
Good morning, everyone, and thank you for joining today's presentation. My name is Courtney O'Leary, Senior Manager of Investor Relations at bluebird bio. Before I begin, let me review our safe harbor statement. Today's discussion contains statements that are forward-looking under the Private Securities Litigation Reform Act of 1995, including statements of the company's plans, expectations and intentions regarding our commercialization plans following the FDA approval of SKYSONA. Such statements are based on current expectations and assumptions that are subject to risks and uncertainties and involve a number of risk factors that could cause actual results to differ materially from projected results.
A description of these risks is contained in our filings with the SEC,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
